8-K
filed April 17, 2024, 7:59 PM ET
ticker IPI
CIK 0001421461
leadership
confidence high
sentiment negative
materiality 0.70
CEO Bob Jornayvaz takes medical leave; CFO Matt Preston appointed acting CEO; co-founder Hugh Harvey rejoins board
Intrepid Potash, Inc.
- CEO Bob Jornayvaz granted temporary medical leave effective April 16, 2024, to recover from previously announced accident.
- CFO Matt Preston appointed acting principal executive officer; will continue as CFO and receive additional $50,000/month.
- Chairman duties temporarily delegated to Lead Director Barth Whitham.
- Board expanded to 7 directors; co-founder Hugh Harvey appointed Class III director, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Matthew D. Preston was appointed as acting principal executive officer at Intrepid Potash, Inc..
- Action
- appointed
- Role
- acting principal executive officer
Exact text from the filing
the Board appointed Matthew D. Preston, the Company’s Chief Financial Officer, as acting principal executive officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Hugh E. Harvey, Jr. was appointed as Class III director at Intrepid Potash, Inc..
- Action
- appointed
- Role
- Class III director
Exact text from the filing
appointed Hugh E. Harvey, Jr. to serve as a Class III director on the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.8
Barth Whitham changed role as Lead Director (acting Chairman) at Intrepid Potash, Inc..
- Action
- delegated chairman responsibilities
- Role
- Lead Director (acting Chairman)
Exact text from the filing
the Board temporarily delegated all responsibilities of the Chairman of the Board to Barth Whitham, Lead Director.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert P. Jornayvaz III changed role as Executive Chairman and Chief Executive Officer at Intrepid Potash, Inc..
- Action
- granted a temporary medical leave of absence
- Role
- Executive Chairman and Chief Executive Officer
Exact text from the filing
granted Robert P. Jornayvaz III, Executive Chairman of the Board and Chief Executive Officer of the Company, a temporary medical leave of absence, effective immediately
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.